| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |